One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion-Reference-Cited by-同舟云学术

One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion

Published:2022-08-04 Issue:9 Volume:50 Page:1038-1046
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clinical Exper Ophthalmology

Author:

Wang Nancy¹^ORCID,Hunt Adrian²,Nguyen Vuong³^ORCID,Shah Janika²⁴,Fraser‐Bell Samantha²,McAllister Ian⁵,Barthelmes Daniel⁶,Gillies Mark²,Squirrell David¹

Affiliation:

1. Department of Ophthalmology University of Auckland Auckland New Zealand

2. University of Sydney, Sydney Medical School, Discipline of Ophthalmology and Eye Health Save Sight Institute New South Wales Australia

3. Clinical Ophthalmology & Eye Health University of Sydney Sydney Australia

4. Clinical Service Department Singapore National Eye Centre Singapore Republic of Singapore

5. Lions Eye Institute University of Western Australia Nedlands Australia

6. Department of Ophthalmology University Hospital of Zurich Zurich Switzerland

Funder

Macular Disease Foundation Australia

Publisher

Wiley

Subject

Ophthalmology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ceo.14139

Reference25 articles.

1. EFFICIENT CAPTURE OF HIGH-QUALITY DATA ON OUTCOMES OF TREATMENT FOR MACULAR DISEASES

2. Twelve‐month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry;Hunt AR;Br J Ophthalmol,2021

3. Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

4. Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion;Ophthalmology Retina;2024-04

2. Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry;Scientific Reports;2024-03-13

3. Systematic review of clinical practice guidelines for the diagnosis and management of retinal vein occlusion;Eye;2024-03-11

4. Systematic review of clinical practice guidelines for the diagnosis and management of retinal vein occlusion;2023-10-19

5. 12-month outcomes of treatment-naïve retinal vein occlusion initially treated with either dexamethasone implants or vascular endothelial growth factor inhibitors: Data from the Fight Retinal Blindness! registry;2023-08-01